Mount Sinai Neurosurgery

🌟Published in the Journal of Neurointerventional Surgery, new insights into aspiration thrombectomy for LVO stroke! The Mount Sinai Health System’s Department of Neurosurgery Cerebrovascular Center led a multicenter study which examined how the positioning of an 8 Fr guide catheter affects the efficacy of endovascular thrombectomy (EVT).   This study analyzed data from multiple comprehensive stroke centers to evaluate the safety and efficacy of intracranial guide catheter placement.   Led by Drs. Daryl Goldman MD, Mais Al-Kawaz, Kurt Yaeger, Trevor Hardigan, Amol Mehta MD, Jacopo Scaggiante, Robert Dana Tomalty, Paul Gulotta, Vernard Sharif Fennell, Gabriel Vidal, Mugilan Poongkunran, James Milburn, Shahram Majidi, and researcher Preethi Reddi, key findings include:   Intracranial positioning of guide catheter was associated with a significantly higher rate of first-pass effect compared to the control group. Similarly, higher positioning of the guide catheter shortened the duration of stroke surgery.    This multicenter study demonstrates that proper utilization of the new generation of guide catheters for intracranial access directly correlates with procedure outcome during endovascular thrombectomy, the authors concluded. 🧠 For the full study, check it out here: https://lnkd.in/e642KadC

Happy Holidays from the Department of Neurosurgery at Mount Sinai Health System! We were so lucky to spend our 2024 holiday party at The Pierre New York, A Taj Hotel in New York City! Thank you to John and Betty Levin for their generosity, making this event possible. ✨

🎉 Congratulations to Robert Rothrock, MD, a proud alumnus of Mount Sinai Health System’s Department of Neurosurgery, for passing his neurosurgery oral board examination and becoming certified by the American Board of Neurological Surgery! 🧠🏅 Dr. Rothrock, Director of Spinal Oncology and Co-Director of Spine Research at Baptist Health South Florida, is also an Assistant Professor of Translational Medicine and Neurosurgery at Florida International University - Herbert Wertheim College of Medicine. We are proud of his accomplishments since graduating from our neurosurgery residency program (Class of 2021). Join us in celebrating Dr. Rothrock! 🌟👏

🧠 Break free from tremors! Join Brian Kopell, MD, Director of the Center for Neuromodulation, for a FREE virtual event on Dec 4th at 2 pm EST. Learn about the latest treatments for #EssentialTremor & Tremor-Dominant Parkinson’s Disease. 🔗 Register now: https://bit.ly/ETPark2024

During the month of November, Mount Sinai Health System’s Department of Neurosurgery recognizes #EpilepsyAwarenessMonth. Saadi Ghatan, MD, epilepsy neurosurgeon and Director of Pediatric Neurosurgery at Mount Sinai, discusses exciting new research at Mount Sinai on Lennox-Gastaut syndrome (LGS). LGS is a rare and severe form of epilepsy that usually begins in early childhood and is characterized by multiple types of seizures. These seizures are often difficult to control with medication and can significantly impact a child's development.   With research at Mount Sinai, both pediatric and adult patients with refractory seizures—those that can't be controlled by medication—are now candidates for a promising treatment: responsive neurostimulation (RNS). This treatment is offering hope for patients who were previously not candidates for brain surgery. 💜🧠

🚨 MEMBRANE Trial Results: Positive Outcome for Middle Meningeal Artery (MMA) Embolization in Chronic subdural hematoma (cSDH)! 🚨   The exciting results of the MEMBRANE trial were presented by Dr. Ansaar Rai at the 2024 SVIN - Society of Vascular and Interventional Neurology Annual Meeting!   cSDH is a common, age-related neurosurgical condition often requiring surgery, but hemorrhage recurrence is high. MMA embolization is a minimally invasive treatment to block off arteries to the dura, which contribute to the hematoma over time. This trial, led by Co-PIs Chris Kellner (Mount Sinai), and Ansaar Rai, MD (West Virginia University), explores its safety and effectiveness for treating cSDH.   MEMBRANE Trial Key Findings: 👉 Positive treatment effect for MMA embolization after 6 months across both cohorts. 👉A prespecified subgroup analysis showing a very strong effect in the surgical subgroup that reached statistical significance despite being underpowered as a subgroup. 👉The strongest benefit observed for patients >75 years requiring surgery. 👉Non-inferior to standard care at 3 months in functional outcomes. 👉MMA embolization with n-BCA reduces hematoma progression or reoperation risk by 50%!   The MEMBRANE study was an international RCT conducted at 30 clinical sites including 2 in China. Christopher Kellner, MD Hazem Shoirah, MD

The inaugural New York Brain Computer Interface (NYBCI) Symposium highlighted why Mount Sinai Health System is a global leader in neurotech and BCI innovation. Hosted by Mount Sinai BioDesign and the Department of Neurosurgery, the event showcased the health system's unique, interdisciplinary approach to advancing brain health through technology.   What sets Mount Sinai apart is its collaborative, tech-forward clinical model that brings together experts from various departments—ensuring that breakthroughs in BCI are not just theoretical but are applied in the clinical setting. Mount Sinai is one of the world's leading neurotech hubs, pushing the limits of what’s possible in brain health.   A special thank you to Joshua Bederson, MD, System Chair of Neurosurgery at Mount Sinai, for his vision and leadership in bringing this remarkable symposium to life. As stated in the article, “Such cross-pollination has been essential to the BCIfield thus far, and serves as a testament to the collegial leadership of Dr. Joshua Bederson.”   The field of BCI is advancing rapidly, and the symposium reinforced that Mount Sinai Health System is at the forefront of BCI’s transformative breakthrough.    Read the full article in Forbes: https://bit.ly/NYBCI24    #NYBCI24 #BCI #Neurotech #Innovation #Neurosurgery #WeFindAWay

🧠 Break free from tremors! Join Dr. Brian Kopell, Director of the Center for Neuromodulation, for a FREE virtual event on Dec 4th at 2 pm EST. Learn about the latest treatments for #EssentialTremor & Tremor-Dominant Parkinson’s Disease. 🔗 Register now: https://bit.ly/ETPark2024

Thank you to the speakers, sponsors, and organizers of the New York Brain Computer Interface Symposium today! I learned so much. From holding a BCI electrode array in my hand, to hearing real BCI patients perspectives, this was such an informative day! Anyone else excited for tomorrow? Precision Neuroscience, Synchron, Mount Sinai Neurosurgery

Had a blast at the NYBCI Symposium these past two days! Very fortunate enough to have met Thomas Oxley (CEO of Synchron), Douglas Weber (CMU Professor in Mechanical Engineering, Head of NeuroMechatronics Lab), John McKinley (Synchron Senior Director of Medical Education and Training), Chad Bouton (professor at Feinstein Institutes for Medical Research), Peter Yoo (Senior Director in Neuroscience and Algorithms at Synchron), Ian Burkhart (North American Spinal Cord Injury Consortium NASCIC President), and many more! Douglas Weber really set the tone for the program as the first speaker, as it was inspiring to hear about his talk on the evolution, current, and future of invasive BCIs, as well as his collaborations with Meta. He is one of my favorite prospective professors to reach out to, from my first choice doctoral program - Neural Computation/Systems Neuroscience PhD at Carnegie Mellon University. Very personable as an individual. I was wonderstruck when I saw Thomas Oxley, whom I had known about since first learning about brain-computer interfaces many months ago. His experience starting up the company and clinical trials galvanized us as young individuals in neurotechnology and neuroscience, teaching us lessons learned along the long journey of the process, from hauling a group of sheep into the laboratories to gaining Seed A funding from angel investors. I was also very thrilled to learn about how the brain-machine integration can be integrated with machine learning from Peter Yoo, which entails capturing the intent, making a model for motor control, and utilizing the model in real-time. As a data science major, this could be extremely helpful for my current projects, such as our club project in building an SSVEP Speller (intent: what key to type, model: ML pipeline with CCA, and utilizing the model for real-time processing). I got the chance to hear about Max Hodak, co-founder and former president of Neuralink. His team made a remarkable milestone of restoring the ability to read a book for blind individuals using ontogenetic technology. It was also very enchanting to be able to witness Ian Burkhart’s story of persistence and resilience, from suffering an accident to founding the BCI Pioneers Coalition. It reinforced the sense of how individuals with SCI could make an impactful difference in the world. Ian’s story would not have been possible without the intervention of Chad Bouton and the Feinstein Institutes for Medical Research team. Their work represented a significant achievement of how someone who has lost senses from SCI can get restored from technology. Along the way, I was also fortunate enough to run into my own course instructor and Neurotech X Columbia club advisor Nima Mesgarani. I was also able to see some fellow Columbia classmates as well, and make new friends along the way. Thank you Mount Sinai Neurosurgery for organizing this amazing event! Looking forward to more similar events soon!